1992
DOI: 10.1128/jcm.30.3.545-551.1992
|View full text |Cite
|
Sign up to set email alerts
|

Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction

Abstract: We report on the development and application of a rapid assay for detecting and typing dengue viruses. Oligonucleotide consensus primers were designed to anneal to any of the four dengue virus types and amplify a 511-bp product in a reverse transcriptase-polymerase chain reaction (PCR). First, we produced a cDNA copy of a portion of the viral genome in a reverse transcriptase reaction in the presence of primer D2 and then carried out a standard PCR (35 cycles of heat denaturation, annealing, and primer extensi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

9
763
0
35

Year Published

1997
1997
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 1,489 publications
(807 citation statements)
references
References 15 publications
(18 reference statements)
9
763
0
35
Order By: Relevance
“…Although, WHO (World Health Organization, 2009) recommends the detection of DENV RNA, as the most effective diagnostic method in the acute phase of the illness, its use is limited due to lack of infrastructure and technical expertise. More recently, molecular techniques to detect virus genomic RNA sequence by the reverse transcription-polymerase chain reaction (RT-PCR) and the real-time quantitative RT-PCR (qRT-PCR) are gradually being accepted as new standards over virus isolation for the detection of DENV in the acute sera (Lanciotti et al, 1992;Shu et al, 2003). These PCR-based methods require either high-precision instruments for the amplification or elaborate methods for detection of the amplified products.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although, WHO (World Health Organization, 2009) recommends the detection of DENV RNA, as the most effective diagnostic method in the acute phase of the illness, its use is limited due to lack of infrastructure and technical expertise. More recently, molecular techniques to detect virus genomic RNA sequence by the reverse transcription-polymerase chain reaction (RT-PCR) and the real-time quantitative RT-PCR (qRT-PCR) are gradually being accepted as new standards over virus isolation for the detection of DENV in the acute sera (Lanciotti et al, 1992;Shu et al, 2003). These PCR-based methods require either high-precision instruments for the amplification or elaborate methods for detection of the amplified products.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, a panel of 50 samples collected from healthy individuals was included as negative controls. Before performing the RT-LAMP assay, all the 350 samples were also screened for DENVspecific RNA by RT-PCR (Lanciotti et al, 1992;Neeraja et al, 2013) and NS1 antigen by Panbio Dengue Early ELISA assay (Inverness Medical Innovations, Australia), Dengue IgG and IgM capture ELISA (Pan Bio, Queensland, Australia).…”
Section: Clinical Samplesmentioning
confidence: 99%
“…A chest radiograph led to testing for SARS-CoV-2 by RT-PCR (in-house laboratory-developed test detecting the N and ORF1ab genes) from a nasopharyngeal swab, which returned positive. The original seropositive sample and additional urine and blood samples tested negative for dengue, chikungunya, and Zika viruses by RT-PCR, [3][4][5] and a repeat dengue rapid test (SD Bioline) was also negative. Thus, the initial dengue seroconversion result was deemed a false positive.…”
mentioning
confidence: 99%
“…We also included three flavivirusnaïve Guangdong residues. DEN-1 infection was confirmed by virus isolation in C6/36 cell culture and subsequent serotype identification with DEN serotype-specific RT-PCR during the viremia-phase (Lanciotti et al, 1992). In addition, DEN infection was also confirmed by using commercial capture-immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assay (ELISA) during the convalescent-phase as described previously (Kuno et al, 1985).…”
Section: Study Populationsmentioning
confidence: 99%